Track CERo Therapeutics Holdings - Warrants (13/02/2029)'s common stock ($93K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (September 2026), CEROW shows a common stock of $93K. That compares with $86K in the prior-year period — up 9.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CEROW's common stock is now $93K (was $86K) — a 9.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CERo Therapeutics Holdings - Warrants (13/02/2029) is outperforming or lagging.
Tracking CEROW's common stock over time shows whether CERo Therapeutics Holdings - Warrants (13/02/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $93K That compares with $86K in the prior-year period — up 9.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has CERo Therapeutics Holdings - Warrants (13/02/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $93K) with ownership activity and broader fundamentals.